Provided by Tiger Trade Technology Pte. Ltd.

HARBOR HEALTH CARE ETF

34.64
+0.41441.21%
Volume:3K
Turnover:89.34K
Market Cap:44.17M
PE:- -
High:34.64
Open:34.48
Low:34.41
Close:34.23
52wk High:35.61
52wk Low:27.50
Shares:1.28M
Float Shares:1.28M
Volume Ratio:0.76
T/O Rate:0.20%
Dividend:0.08
Dividend Rate:0.22%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

FDA Greenlights Roche and Eli Lilly's Blood-Based Alzheimer's Test, Setting a Single Threshold to Rule Both In and Out Amyloid Pathology

Deep News
·
Aug 25

Moderna Inc Stock (MRNA) Moved Up by 10.02% on Aug 25: Drivers Behind the Movement

TradingKey
·
Aug 25

Stick with Value Stocks Until Everyone Starts Talking About Them - and as of Now They're Still Under the Radar, This Wall Street Firm Says

Dow Jones
·
Aug 25

Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE) and Rhythm Pharmaceuticals (RYTM)

TIPRANKS
·
Aug 25

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Eli Lilly & Co (LLY)

TIPRANKS
·
Aug 25

Moderna Inc. Stock Slides 4.3%, Underperforms Peers

Dow Jones
·
Aug 25

Ascendis Pharma (ASND) On Profitability, The Valuation Narrative Still Points To Upside

Simply Wall St.
·
Aug 25

Lakefront Biotherapeutics Wins FDA Orphan Drug Status for Gamgertamig in Pemphigus

Reuters
·
Aug 25

Eli Lilly Stock (LLY) in Focus as Hedge Fund Titan Ken Griffin Quadruples Position

TIPRANKS
·
Aug 25

Sector Update: Healthcare

MT Newswires Live
·
Aug 25

Eli Lilly’s New Obesity Drug LY3549492 Moves Forward With Completed Phase 1 Trial

TIPRANKS
·
Aug 25

Eli Lilly (LLY) On Foundayo Launch And Higher Outlook Faces A Rich Valuation

Simply Wall St.
·
Aug 24

Rhythm Pharma Says Japan Regulator Approves Imcivree for Acquired Hypothalamic Obesity

Reuters
·
Aug 24

Rhythm Pharmaceuticals, - Imcivree Launch in Japan Expected by End of 2026 Pending Pricing

THOMSON REUTERS
·
Aug 24

Roche, Eli Lilly's Alzheimer's Blood Test Gets FDA Clearance

Reuters
·
Aug 24

EU Commission Approves Gilead Trodelvy-Keytruda Combo for First-Line PD-L1+ Metastatic TNBC

Reuters
·
Aug 24

Gilead - EU Grants Marketing Authorization for Trodelvy with Keytruda in First-Line Pd-L1-Positive Metastatic Tnbc

THOMSON REUTERS
·
Aug 24

European Commission Expands Role of Gilead’s Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer Across Pd-L1 Status

THOMSON REUTERS
·
Aug 24

Barclays Sticks to Its Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
Aug 24

Eli Lilly: Working with Nice on Assessment of Foundayo for Potential Use on Nhs in England

THOMSON REUTERS
·
Aug 24